IP Library › Granted Patent US 12,350,502
Granted Patent B2
US 12,350,502 · App. 17/450,922 · Granted Jul 8, 2025

Electrodes for intra-cardiac pacemaker

Inventors: Zhongping Yang (Woodbury, MN); Becky L. Dolan (Chisago, MN); Xin Chen (Blaine, MN); Thomas A. Anderson (New Hope, MN); Berthold Stegemann (Kassel, DE); Maurice Verbeek (Maastricht, NL)
Assignee: Medtronic, Inc.
A61N1/3756A61N1/0573A61N1/368A61N1/37512A61N1/3752A61N1/0504A61N2001/058A61N1/3621A61N1/37518
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,350,502
App. No.
17/450,922
Filed
Oct 14, 2021
Granted
Jul 8, 2025
Kind
B2
Art Unit
3792
USPC
607/126
Abstract

A pacemaker has a housing and a therapy delivery circuit enclosed by the housing for generating pacing pulses for delivery to a patient's heart. An electrically insulative distal member is coupled directly to the housing and at least one non-tissue piercing cathode electrode is coupled directly to the insulative distal member. A tissue piercing electrode extends away from the housing.

Claims (53)

1. A pacemaker comprising:

a housing having a proximal end, a distal end and a longitudinal sidewall extending from the proximal end to the distal end;

a therapy delivery circuit enclosed by the housing configured to generate pacing pulses for delivery to a patient's heart;

an anode electrode defined by an electrically conductive portion of the longitudinal sidewall;

an electrically insulative distal member coupled to the housing distal end, the electrically insulative distal member defining a distal surface and a circumferential surface circumscribing the housing distal end;

at least one non-tissue piercing cathode electrode coupled directly to the circumferential surface and electrically coupled to the therapy delivery circuit for delivering a first portion of the generated pacing pulses via a first pacing electrode vector including the at least one non-tissue piercing cathode electrode and the anode electrode;

a tissue piercing electrode extending away from the housing distal end for delivering a second portion of the generated pacing pulses,

wherein the pacemaker is configured to implant within a chamber of a heart, and

wherein the tissue piercing electrode is configured to deliver pacing pulses to the ventricular conduction system of the heart when the pacemaker implants within the chamber of the heart; and

a sensing circuit enclosed by the housing;

an atrial sensing channel electrically coupled to the at least one non-tissue piercing cathode electrode, wherein the atrial sensing channel is configured to receive a first cardiac electrical signal indicative of a P-wave of the patient's heart, and wherein the atrial sensing channel is configured to determine when the P-wave crosses a P-wave sensing threshold and communicate a first signal to the sensing circuit when the P-wave crosses the P-wave sensing threshold; and

a ventricular sensing channel electrically coupled to the tissue piercing electrode, wherein the ventricular sensing channel is configured to receive a second cardiac electrical signal indicative of an R-wave of the patient's heart, and wherein ventricular sensing channel is configured to determine when the R-wave crosses an R-wave sensing threshold and communicate a second signal to the sensing circuit when the R-wave crosses the R-wave sensing threshold.

2. The pacemaker of claim 1 , wherein the tissue piercing electrode is configured to deliver the second portion of the generated pacing pulses to at least one of a Bundle of His of the heart, bundle branches of the heart, or Purkinje fibers of the heart when the tissue piercing electrode delivers pacing pulses to the ventricular conduction system.

3. The pacemaker of claim 1 , wherein the tissue piercing electrode is configured to position in contact with a portion of the ventricular conduction system of the heart when the pacemaker implants within the chamber of the heart.

4. The pacemaker of claim 3 , wherein the tissue piercing electrode is configured to position in contact with at least one of a Bundle of His of the heart, bundle branches of the heart, or Purkinje fibers of the heart when the tissue piercing electrode positions in contact with the portion of the ventricular conduction system.

5. The pacemaker of claim 1 , wherein the pacemaker is configured to implant within a right atrium of the heart.

6. The pacemaker of claim 1 , wherein the pacemaker is configured to implant in a target implant region between a Bundle of His of the heart and a coronary sinus of the heart.

7. The pacemaker of claim 1 , wherein the ventricular sensing channel is configured to receive the second cardiac electrical signal from the ventricular conduction system and communicate a signal indicative of the second cardiac electrical signal to the sensing circuit for detection of ventricular depolarizations.

8. The pacemaker of claim 1 , wherein:

the atrial sensing channel includes first cardiac event detection circuitry configured to detect the P-wave, and

the ventricular sensing channel includes second cardiac event detection circuitry configured to detect the R-wave.

9. The pacemaker of claim 1 , wherein the tissue piercing electrode is configured to deliver the second portion of the generated pacing pulses via a second pacing electrode vector including the tissue piercing electrode and at least one of the anode electrode or the at least one non-tissue piercing electrode.

10. The pacemaker of claim 1 , wherein the at least one non-tissue piercing cathode electrode is coupled directly to the distal surface.

11. The pacemaker of claim 10 , further comprising:

a plurality of electrical conductors, wherein each individual conductor in the plurality of electrical conductors is configured to couple an individual non-tissue piercing electrode in the plurality of non-tissue piercing electrodes to the therapy delivery circuit,

switching circuitry configured to cause the each individual conductor to couple the individual non-tissue piercing electrode to the therapy delivery circuit for delivery of the first portion of the generated pacing pulses.

12. The pacemaker of claim 1 , further comprising a fixation member configured to anchor the distal end of the pacemaker in a target implant region in the chamber of the heart.

13. The pacemaker of claim 12 , wherein the fixation member is an active fixation member comprising an electrically insulated shaft extending from a proximal shaft end coupled to the housing distal end to a distal shaft end, wherein the electrically insulated shaft supports the tissue piercing electrode.

14. A pacemaker comprising:

a housing having a proximal end, a distal end and a longitudinal sidewall extending from the proximal end to the distal end;

a therapy delivery circuit enclosed by the housing for generating pacing pulses for delivery to a patient's heart;

an anode electrode defined by an electrically conductive portion of the housing;

an electrically insulative distal member coupled to the housing distal end, the electrically insulative distal member defining a distal surface and a circumferential surface circumscribing the housing distal end;

at least one non-tissue piercing cathode electrode coupled directly to the circumferential surface and electrically coupled to the therapy delivery circuit for delivering a first portion of the generated pacing pulses via a first pacing electrode vector including the at least one non-tissue piercing cathode electrode and the anode electrode;

a tissue piercing electrode extending away from the housing distal end for delivering a second portion of the generated pacing pulses; and

a fixation member configured to anchor the distal end of the pacemaker in a target implant region in the chamber of the heart,

wherein the pacemaker is configured to implant within a chamber of a heart, and

wherein the tissue piercing electrode is configured to deliver pacing pulses to at least one of a Bundle of His of the heart, bundle branches of the heart, or Purkinje fibers of the heart when the pacemaker implants within the chamber of the heart;

a sensing circuit enclosed by the housing;

an atrial sensing channel electrically coupled to the at least one non-tissue piercing cathode electrode, wherein the atrial sensing channel is configured to receive a first cardiac electrical signal indicative of a P-wave of the patient's heart, and wherein the atrial sensing channel is configured to determine when the P-wave crosses a P-wave sensing threshold and communicate a first signal to the sensing circuit when the P-wave crosses the P-wave sensing threshold;

a ventricular sensing channel electrically coupled to the tissue piercing electrode, wherein the ventricular sensing channel is configured to receive a second cardiac electrical signal indicative of an R-wave of the patient's heart, and wherein ventricular sensing channel is configured to determine when the R-wave crosses an R-wave sensing threshold and communicate a second signal to the sensing circuit when the R-wave crosses the R-wave sensing threshold; and

a control circuit enclosed by the housing, wherein the control circuit is configured to control the delivery of the first portion of the generated pacing pulses and control the delivery of the second portion of the generated pacing pulses using the first signal and the second signal.

15. The pacemaker of claim 14 ,

wherein the sensing circuit is configured to detect atrial depolarizations using the first signal and

configured to detect ventricular depolarizations using the second signal.

16. The pacemaker of claim 14 , wherein the at least one non-tissue piercing cathode electrode comprises a plurality of non-tissue piercing electrodes, wherein each electrode of the plurality of non-tissue piercing electrodes is coupled directly to the distal surface and coupled directly to the circumferential surface.

17. A method, comprising:

delivering a first portion of generated pacing pulses via a first pacing electrode vector using at least one non-tissue piercing cathode electrode of a pacemaker and an anode electrode of the pacemaker, wherein the at least one non-tissue piercing cathode electrode is electrically coupled to a therapy delivery circuit configured to generate the pacing pulses for delivery to a patient's heart, wherein the non-tissue piercing electrode is coupled directly to a circumferential surface of an insulative distal member, the insulative distal member coupled to a distal end of a housing of the pacemaker having a proximal end, the distal end and a longitudinal sidewall extending from the proximal end to the distal end, and the circumferential surface circumscribing the distal end of the housing, wherein the therapy delivery circuit is enclosed by the housing, and wherein the anode electrode is defined by an electrically conductive portion of the housing; and

delivering a second portion of the generated pacing pulses using a tissue piercing electrode extending away from the housing distal end, herein the pacemaker is configured to implant within a chamber of a heart, wherein the tissue piercing electrode is configured to deliver pacing pulses to the ventricular conduction system of the heart when the pacemaker implants within the chamber of the heart, the pacemaker further comprising:

a sensing circuit enclosed by the housing,

an atrial sensing channel electrically coupled to the at least one non-tissue piercing cathode electrode, wherein the atrial sensing channel is configured to receive a first cardiac electrical signal indicative of a P-wave of the patient's heart, and wherein the atrial sensing channel is configured to determine when the P-wave crosses a P-wave sensing threshold and communicate a first signal to the sensing circuit when the P-wave crosses the P-wave sensing threshold, and

a ventricular sensing channel electrically coupled to the tissue piercing electrode, wherein the ventricular sensing channel is configured to receive a second cardiac electrical signal indicative of an R-wave of the patient's heart, and wherein ventricular sensing channel is configured to determine when the R-wave crosses an R-wave sensing threshold and communicate a second signal to the sensing circuit when the R-wave crosses the R-wave sensing threshold.

18. The method of claim 17 , further comprising delivering the second portion of the generated pacing pulses to at least one of a Bundle of His of the heart, bundle branches of the heart, or Purkinje fibers of the heart when the tissue piercing electrode delivers pacing pulses to the ventricular conduction system.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2021
From: YANG, ZHONGPING; DOLAN, BECKY L.; CHEN, XIN; ANDERSON, THOMAS A.; VERBEEK, MAURICE; STEGEMANN, BERTHOLD
To: MEDTRONIC, INC.
Reel/Frame 058051/0007 →
Continuity (4)
Continuation 16130272 · Sep 13, 2018
Provisional Application 62583075 · Nov 8, 2017
Provisional Application 62559106 · Sep 15, 2017
Related Publication 20220062630A1 · Mar 3, 2022
References Cited (146)
US 3700181A · Diring et al. · 1972 [cited by applicant]
US 3814104A · Irnich et al. · 1974 [cited by applicant]
US 3943936A · Rasor et al. · 1976 [cited by applicant]
US 4103690A · Harris · 1978 [cited by applicant]
US 4142530A · Wittkampf · 1979 [cited by applicant]
US 4269198A · Stokes · 1981 [cited by applicant]
US 4280512A · Karr et al. · 1981 [cited by applicant]
US 4858623A · Bradshaw et al. · 1989 [cited by applicant]
US 4936823A · Colvin · 1990 [cited by applicant]
US 5193540A · Schulman et al. · 1993 [cited by applicant]
US 5306292A · Lindegren · 1994 [cited by applicant]
US 5411535A · Fujii et al. · 1995 [cited by applicant]
US 5573540A · Yoon · 1996 [cited by applicant]
US 5683447A · Bush et al. · 1997 [cited by applicant]
US 6007558A · Ravenscroft et al. · 1999 [cited by applicant]
US 6151525A · Soykan et al. · 2000 [cited by applicant]
US 6240322B1 · Peterfeso et al. · 2001 [cited by applicant]
US 6286512B1 · Loeb et al. · 2001 [cited by applicant]
US 6409674B1 · Brockway et al. · 2002 [cited by applicant]
US 6575967B1 · Leveen et al. · 2003 [cited by applicant]
US 6783499B2 · Schwartz · 2004 [cited by applicant]
US 6915149B2 · Ben-Haim · 2005 [cited by applicant]
US 6978178B2 · Sommer et al. · 2005 [cited by applicant]
US 7290743B2 · Nowack · 2007 [cited by applicant]
US 7383091B1 · Chitre et al. · 2008 [cited by applicant]
US 7418298B2 · Shiroff et al. · 2008 [cited by applicant]
US 7532933B2 · Hastings et al. · 2009 [cited by applicant]
US 8332036B2 · Hastings et al. · 2012 [cited by applicant]
US 8353940B2 · Benderev · 2013 [cited by applicant]
US 8478408B2 · Hastings et al. · 2013 [cited by applicant]
US 8634912B2 · Bornzin et al. · 2014 [cited by applicant]
US 8634919B1 · Hou et al. · 2014 [cited by applicant]
US 8700181B2 · Bornzin · 2014 [cited by examiner]
US 8798740B2 · Samade et al. · 2014 [cited by applicant]
US 8914131B2 · Bornzin et al. · 2014 [cited by applicant]
US 8923963B2 · Bonner et al. · 2014 [cited by applicant]
US 8948883B2 · Eggen et al. · 2015 [cited by applicant]
US 8996109B2 · Karst et al. · 2015 [cited by applicant]
US 9072911B2 · Hastings et al. · 2015 [cited by applicant]
US 9119959B2 · Rys et al. · 2015 [cited by applicant]
US 9278218B2 · Karst et al. · 2016 [cited by applicant]
US 9393424B2 · Demmer · 2016 [cited by examiner]
US 9393427B2 · Schmidt · 2016 [cited by examiner]
US 9399139B2 · Demmer et al. · 2016 [cited by applicant]
US 9399140B2 · Cho et al. · 2016 [cited by applicant]
US 9492668B2 · Sheldon et al. · 2016 [cited by applicant]
US 9492669B2 · Demmer et al. · 2016 [cited by applicant]
US 9526891B2 · Eggen et al. · 2016 [cited by applicant]
US 9579500B2 · Rys et al. · 2017 [cited by applicant]
US 10532203B2 · Thompson-Nauman et al. · 2020 [cited by applicant]
US 20020103424A1 · Swoyer et al. · 2002 [cited by applicant]
US 20020165589A1 · Imran et al. · 2002 [cited by applicant]
US 20020183817A1 · Van Venrooij et al. · 2002 [cited by applicant]
US 20030088301A1 · King · 2003 [cited by applicant]
US 20030105501A1 · Warman et al. · 2003 [cited by applicant]
US 20030220676A1 · Helland · 2003 [cited by examiner]
US 20040147973A1 · Hauser · 2004 [cited by applicant]
US 20040230281A1 · Heil et al. · 2004 [cited by applicant]
US 20040230283A1 · Prinzen et al. · 2004 [cited by applicant]
US 20060084965A1 · Young · 2006 [cited by applicant]
US 20060085039A1 · Hastings et al. · 2006 [cited by applicant]
US 20060085041A1 · Hastings et al. · 2006 [cited by applicant]
US 20060217621A1 · Kim et al. · 2006 [cited by applicant]
US 20060235476A1 · Gunderson et al. · 2006 [cited by applicant]
US 20080215127A1 · Chitre et al. · 2008 [cited by applicant]
US 20090082828A1 · Ostroff · 2009 [cited by applicant]
US 20090318993A1 · Eidenschink et al. · 2009 [cited by applicant]
US 20100286626A1 · Petersen et al. · 2010 [cited by applicant]
US 20100318147A1 · Forslund · 2010 [cited by examiner]
US 20110190842A1 · Johnson et al. · 2011 [cited by applicant]
US 20110237967A1 · Moore et al. · 2011 [cited by applicant]
US 20120158111A1 · Khairkhahan · 2012 [cited by examiner]
US 20120172892A1 · Grubac · 2012 [cited by examiner]
US 20130035748A1 · Bonner et al. · 2013 [cited by applicant]
US 20130110127A1 · Bornzin et al. · 2013 [cited by applicant]
US 20130123872A1 · Bornzin · 2013 [cited by examiner]
US 20130138006A1 · Bornzin · 2013 [cited by examiner]
US 20130197609A1 · Moore et al. · 2013 [cited by applicant]
US 20130324825A1 · Ostroff et al. · 2013 [cited by applicant]
US 20130325081A1 · Karst et al. · 2013 [cited by applicant]
US 20140039591A1 · Drasler et al. · 2014 [cited by applicant]
US 20140067036A1 · Shuros · 2014 [cited by examiner]
US 20140107723A1 · Hou · 2014 [cited by examiner]
US 20140303704A1 · Suwito et al. · 2014 [cited by applicant]
US 20150039070A1 · Kuhn et al. · 2015 [cited by applicant]
US 20150051616A1 · Haasl · 2015 [cited by examiner]
US 20150057558A1 · Stahmann · 2015 [cited by examiner]
US 20150057721A1 · Stahmann · 2015 [cited by examiner]
US 20150088155A1 · Stahmann et al. · 2015 [cited by applicant]
US 20150306378A1 · Schmidt · 2015 [cited by examiner]
US 20150321012A1 · Cinbis · 2015 [cited by examiner]
US 20150321016A1 · O'Brien · 2015 [cited by examiner]
US 20160015287A1 · Anderson et al. · 2016 [cited by applicant]
US 20160015322A1 · Anderson et al. · 2016 [cited by applicant]
US 20160015984A1 · Demmer · 2016 [cited by examiner]
US 20160059002A1 · Grubac et al. · 2016 [cited by applicant]
US 20160067486A1 · Brown · 2016 [cited by examiner]
US 20160067490A1 · Carney et al. · 2016 [cited by applicant]
US 20160067500A1 · Demmer · 2016 [cited by examiner]
US 20160114161A1 · Amblard et al. · 2016 [cited by applicant]
US 20160114169A1 · Sheldon · 2016 [cited by examiner]
US 20160144190A1 · Cao · 2016 [cited by examiner]
US 20160250478A1 · Greenhut · 2016 [cited by examiner]
US 20160250480A1 · Sheldon · 2016 [cited by examiner]
US 20160310722A1 · Demmer · 2016 [cited by applicant]
US 20160310733A1 · Sheldon et al. · 2016 [cited by applicant]
US 20160310749A1 · Moore et al. · 2016 [cited by applicant]
US 20170056670A1 · Sheldon et al. · 2017 [cited by applicant]
US 20170209689A1 · Chen et al. · 2017 [cited by applicant]
US 20180028814A1 · Ghosh · 2018 [cited by applicant]
US 20180050208A1 · Shuros et al. · 2018 [cited by applicant]
US 20190030346A1 · Li · 2019 [cited by examiner]
US 20190083779A1 · Yang et al. · 2019 [cited by applicant]
US 20190083800A1 · Yang et al. · 2019 [cited by applicant]
CN 103328040A · 2013 [cited by applicant]
CN 104491986A · 2015 [cited by applicant]
CN 105377364A · 2016 [cited by applicant]
CN 106232178A · 2016 [cited by applicant]
EP 2826522A1 · 2015 [cited by applicant]
WO 2002022202A2 · 2002 [cited by applicant]
WO 2006118865A2 · 2006 [cited by applicant]
WO 2015127009A1 · 2015 [cited by applicant]
WO 2016171891A1 · 2016 [cited by applicant]
Examination Report from counterpart European Application No. 18779546.3, dated Feb. 26, 2021, 3 pp. [cited by applicant]
(PCT/US2018/050988) PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, Mailed Nov. 14, 2018, 11 pages. [cited by applicant]
Prosecution History from U.S. Appl. No. 16/130,292, dated Aug. 17, 2020 through Oct. 8, 2021, 53 pp. [cited by applicant]
Yang et al., “Implantable Medical Device With Retractable Fixation Sheath”, U.S. Appl. No. 15/705,690, filed Sep. 15, 2017, 55 pages. [cited by applicant]
Response to European Search Report dated Feb. 26, 2021, from counterpart European application number 18779546.3, filed Sep. 7, 2021, 11 pp. [cited by applicant]
Prosecution History from U.S. Appl. No. 16/130,272, dated Aug. 14, 2020 through Sep. 21, 2021, 66 pp. [cited by applicant]
Advisory Action from U.S. Appl. No. 16/130,292, dated Dec. 13, 2021, 2 pp. [cited by applicant]
Amendment in Response to Final Office Action mailed Oct. 8, 2021, from U.S. Appl. No. 16/130,292, filed Nov. 30, 2021, 21 pp. [cited by applicant]
Notice of Allowance from U.S. Appl. No. 16/130,272, dated Jan. 4, 2022, 7 pp. [cited by applicant]
Haqqani et al., “The Implantable Cardioverter-Defibrillator Lead: Principles, Progress and Promises,” PACE, vol. 32, Oct. 2009, pp. 1336-1353. [cited by applicant]
Notice of Allowance from U.S. Appl. No. 16/130,272, dated Apr. 14, 2022, 5 pp. [cited by applicant]
Notice of Allowance from U.S. Appl. No. 16/130,292, dated Jun. 15, 2022, 5 pp. [cited by applicant]
Notice of Allowance from U.S. Appl. No. 16/130,292, dated Mar. 28, 2022, 8 pp. [cited by applicant]
Tjong et al., “Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator,” JACC: Clinical Electrophysiology, vol. 3, No. 13, Dec. 26, 2017, pp. 1487-1… [cited by applicant]
Tjong et al., “The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD,” Herzschrittmachertherapie + Elektrophysiologie, vol. 29, Oct. 31, 2018, pp. 355-361. [cited by applicant]
Notice of Allowance from U.S. Appl. No. 17/932,242 dated Jun. 18, 2024, 7 pp. [cited by applicant]
Response to Final Office Action dated Mar. 27, 2024 from U.S. Appl. No. 17/932,242, filed May 24, 2024, 9 pp. [cited by applicant]
First Office Action and Search Report, and translation thereof, from counterpart Chinese Application No. 201880059594.X dated Jan. 6, 2023, 9 pp. [cited by applicant]
Final Office Action from U.S. Appl. No. 17/932,242 dated Mar. 27, 2024, 7 pp. [cited by applicant]
Second Office Action from counterpart Chinese Application No. 201880059614.3 dated Sep. 1, 2023, 11 pp. [cited by applicant]
Office Action from U.S. Appl. No. 17/932,242 dated Jan. 16, 2025, 17 pp. [cited by applicant]
Final Office Action from U.S. Appl. No. 17/932,242 dated May 1, 2025, 13 pp. [cited by applicant]
Response to Office Action dated Jan. 16, 2025 from U.S. Appl. No. 17/932,242, filed Apr. 8, 2025, 15 pp. [cited by applicant]